Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and ...

TUKYSA in combination with trastuzumab and pertuzumab showed more than 50% improvement in median progression-free survival, ...

Med Center Health is the first hospital in the region, and the seventh in the state, to offer a new treatment for patients ...

The new targeted therapy is designed to block KRAS, a protein that drives many pancreatic cancers, and its approval ...

Revolution Medicines' daraxonrasib is the first drug that can broadly tackle one of the main drivers of pancreatic cancer.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A new targeted cancer drug offers a superior first-line treatment for aggressive ...

Lung cancer is still the top cancer killer, but new developments are shifting what the future might hold for patients.

A research team has developed an anticancer treatment platform that simultaneously targets cancer cells and the surrounding ...

Lyrfigtu (lirafugratinib), a once-daily pill, is for previously treated cholangiocarcinoma with an FGFR2 fusion or ...

More than 100 Vietnamese and Korean doctors gathered in Hanoi to discuss advances in breast cancer diagnosis and treatment, including less invasive surgery, personalized therapies and artificial ...

Molecules spun off from a cancer drug may have a second job in fighting malaria. Researchers at the University of São Paulo’s ...